Eiger BioPharmaceuticals, Inc.

CIK 1305253 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Eiger BioPharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Oct 1, 202415-12G0001193125-24-229473
Oct 1, 20248-K0001193125-24-229453
Sep 9, 20248-K0001193125-24-215909
Sep 4, 20248-K0001193125-24-212606
Sep 3, 20248-K0001193125-24-211486
Aug 26, 2024SC 13G0001178913-24-002771
Aug 2, 20248-K0001193125-24-192887
Aug 1, 20248-K0001193125-24-190550
Jul 16, 20248-K0001193125-24-179313
Jul 10, 20248-K0001193125-24-177016
Jul 1, 2024SC 13D/A0001178913-24-002107
Jul 1, 20248-K0001193125-24-172678
Jun 21, 20248-K0001193125-24-165736
Jun 14, 20248-K0001193125-24-161203
May 28, 20248-K0001193125-24-147523
May 10, 2024SC 13G/A0001193125-24-136030
May 2, 20248-K0001193125-24-129415
Apr 29, 202410-K/A0001193125-24-122498
Apr 25, 202425-NSE0001354457-24-000305
Apr 8, 202410-K0001628280-24-015297
Apr 3, 20248-K0001193125-24-086059
Apr 1, 2024S-8 POS0001193125-24-083552
Apr 1, 2024S-8 POS0001193125-24-083521
Apr 1, 2024S-8 POS0001193125-24-083517
Apr 1, 2024S-8 POS0001193125-24-083528